GNL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.413600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.895200E-01
Normal-vs-Stage2
2.222800E-01
Normal-vs-Stage3
6.379800E-01
Normal-vs-Stage4
8.14050000000899E-05
Stage1-vs-Stage2
4.721400E-01
Stage1-vs-Stage3
9.346800E-01
Stage1-vs-Stage4
7.281500E-03
Stage2-vs-Stage3
4.953200E-01
Stage2-vs-Stage4
5.60119999999387E-05
Stage3-vs-Stage4
1.904570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.503800E-01
Normal-vs-AfricanAmerican
3.170600E-01
Normal-vs-Asian
6.592300E-02
Caucasian-vs-AfricanAmerican
8.227800E-01
Caucasian-vs-Asian
9.656600E-01
AfricanAmerican-vs-Asian
8.377200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.030800E-01
Normal-vs-Female
1.836040E-01
Male-vs-Female
4.250600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.366200E-01
Normal-vs-Age(41-60Yrs)
7.107600E-02
Normal-vs-Age(61-80Yrs)
2.575100E-03
Normal-vs-Age(81-100Yrs)
3.032200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.838400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.891400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.852400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.123600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.866200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.328400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.159380E-01
Normal-vs-Daily Drinker
5.406200E-02
Normal-vs-Weekly Drinker
2.732000E-02
Normal-vs-Occasional Drinker
2.904300E-02
Normal-vs-Social Drinker
1.892020E-02
Non Drinker-vs-Daily Drinker
6.751000E-01
Non Drinker-vs-Weekly Drinker
2.069000E-01
Non Drinker-vs-Occasional Drinker
5.830500E-02
Non Drinker-vs-Social Drinker
6.743900E-02
Daily Drinker-vs-Weekly Drinker
3.709200E-01
Daily Drinker-vs-Occasional Drinker
1.897380E-01
Daily Drinker-vs-Social Drinker
2.138600E-01
Weekly Drinker-vs-Occasional Drinker
9.836400E-01
Weekly Drinker-vs-Social Drinker
9.669200E-01
Occasional Drinker-vs-Social Drinker
9.114800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.502400E-01
Normal-vs-Grade 2
9.808600E-01
Normal-vs-Grade 3
9.551400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.613990E-02
Grade 1-vs-Grade 3
5.023900E-02
Grade 1-vs-Grade 4
8.502400E-01
Grade 2-vs-Grade 3
4.292000E-01
Grade 2-vs-Grade 4
9.808600E-01
Grade 3-vs-Grade 4
9.551400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.868390E-02
Normal-vs-NonDiabetic
2.426400E-01
Diabetic-vs-NonDiabetic
3.890800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.648000E-02
Normal-vs-NoPancreatitis
3.195200E-01
Pancreatitis-vs-NoPancreatitis
1.460230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.155000E-01
Normal-vs-N1
2.284400E-01
N0-vs-N1
7.824200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.328440E-01
Normal-vs-TP53-NonMutant
6.094000E-01
TP53-Mutant-vs-TP53-NonMutant
1.006160E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
